Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Autoimmunity: Will worms cure rheumatoid arthritis?

Shor DB, Shoenfeld Y.

Nat Rev Rheumatol. 2013 Mar;9(3):138-40. doi: 10.1038/nrrheum.2013.3. Epub 2013 Jan 29. No abstract available.

PMID:
23358506
2.

Dendritic cells and their potential implication in pathology and treatment of rheumatoid arthritis.

Wenink MH, Han W, Toes RE, Radstake TR.

Handb Exp Pharmacol. 2009;(188):81-98. doi: 10.1007/978-3-540-71029-5_4. Review.

PMID:
19031022
3.

Gene therapy for rheumatoid arthritis?

Feldmann M.

J Clin Invest. 2001 Jun;107(11):1353. No abstract available.

4.

The role of interleukin-17 in the pathogenesis of rheumatoid arthritis.

Gaffen SL.

Curr Rheumatol Rep. 2009 Oct;11(5):365-70. Review.

5.

T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices?

Kinne RW, Palombo-Kinne E, Emmrich F.

Biochim Biophys Acta. 1997 Apr 12;1360(2):109-41. Review. No abstract available.

6.

Is There a Future for Interleukin 17 Blocking Agents in Rheumatoid Arthritis?

Durez P.

J Rheumatol. 2016 Mar;43(3):465-7. doi: 10.3899/jrheum.160010. No abstract available.

PMID:
26932985
7.

Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.

Bai F, Tian H, Niu Z, Liu M, Ren G, Yu Y, Sun T, Li S, Li D.

Int J Mol Med. 2014 Mar;33(3):711-21. doi: 10.3892/ijmm.2013.1611. Epub 2013 Dec 27.

PMID:
24378614
8.

[Role of Th17 cells in rheumatoid arthritis].

Himer L, Balog A, Szebeni B, Szak√°l DN, Sziksz E, Reusz G, Tulassay T, Vannay A.

Orv Hetil. 2010 Jun 20;151(25):1003-10. doi: 10.1556/OH.2010.28880. Review. Hungarian.

PMID:
20519185
9.

Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models.

Iwakura Y.

Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):341-55. Review.

PMID:
12220548
10.

Possible roles of IL-12-family cytokines in rheumatoid arthritis.

Pope RM, Shahrara S.

Nat Rev Rheumatol. 2013 Apr;9(4):252-6. doi: 10.1038/nrrheum.2012.170. Epub 2012 Oct 23. Review.

PMID:
23090510
11.

Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.

Williams RO, Paleolog E, Feldmann M.

Curr Opin Pharmacol. 2007 Aug;7(4):412-7. Epub 2007 Jul 12. Review.

PMID:
17627887
12.

Pineal gland in autoimmunity: melatonin-dependent exaggeration of collagen-induced arthritis in mice.

Mattsson R, Hannsson I, Holmdahl R.

Autoimmunity. 1994;17(1):83-6. No abstract available.

PMID:
8025216
13.

The microbiome, autoimmunity, and arthritis: cause and effect: an historical perspective.

Paget SA.

Trans Am Clin Climatol Assoc. 2012;123:257-66; discussion 266-7. No abstract available.

14.

[Of worms and men--Administration of helminth products as an innovative approach to treatment of autoimmune diseases].

Sega Y, Versini M, Shoenfeld Y.

Harefuah. 2015 Jul;154(7):428-31, 470, 469. Review. Hebrew.

PMID:
26380461
15.

Targeting IL-17 and Th17 cells in rheumatoid arthritis.

Sarkar S, Fox DA.

Rheum Dis Clin North Am. 2010 May;36(2):345-66. doi: 10.1016/j.rdc.2010.02.006. Review.

PMID:
20510238
16.

Systemic humoral autoimmunity but joint-specific inflammation: the syndrome of rheumatoid arthritis.

Wu X, Shih F, Atkinson JP.

Arthritis Rheum. 2007 Sep;56(9):2823-8. No abstract available.

17.

[Role of Th17 cells and innate immunnity for the induction of autoimmune arthritis].

Hashimoto M, Mimori T.

Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(6):463-9. Review. Japanese.

18.

Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.

Paunovic V, Carroll HP, Vandenbroeck K, Gadina M.

Rheumatology (Oxford). 2008 Jun;47(6):771-6. doi: 10.1093/rheumatology/kem352. Epub 2008 Jan 31. Review.

PMID:
18238793
19.

Immunomodulation in human and experimental arthritis: including vitamin D, helminths and heat-shock proteins.

Ishikawa LL, Shoenfeld Y, Sartori A.

Lupus. 2014 May;23(6):577-87. doi: 10.1177/0961203314527369. Review.

PMID:
24763541
20.

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.

Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH; Psoriasis Study Group, Durez P, Tak PP, Gomez-Reino JJ; Rheumatoid Arthritis Study Group, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD; Uveitis Study Group, Rose K, Haider A, Di Padova F.

Sci Transl Med. 2010 Oct 6;2(52):52ra72. doi: 10.1126/scitranslmed.3001107.

Supplemental Content

Support Center